Dr. Wayne D Bierbaum, M.D Internal Medicine Medicare: Medicare Enrolled Practice Location: 134 Owensville Rd, West River, MD 20778 Phone: 410-867-4700 Fax: 410-867-4934 |
News Archive
A Toronto Star editorial reflects on the pledges of G8 countries to the Muskoka Initiative to improve maternal and child health care, noting, while Canada's $1.1 billion over five years "fell noticeably short of the $1.2 billion the G8 and G20 summits cost to stage, it will lend welcome impetus to a lifeline for Africa and help save lives." However, as the editorial notes, "the recession-battered G8 as a group responded feebly, mustering only $5 billion over five years.
Oncolytics Biotech® Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY), a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its lead product candidate, REOLYSIN®, for the treatment of pancreatic cancer.
Cell Therapeutics, Inc. today announced that the Italian Medicines Agency ("AIFA"), the national authority responsible for drug regulation in Italy, has approved the facility at NerPharMa DS (a pharmaceutical manufacturing company belonging to Nerviano Medical Sciences Srl, in Nerviano, Italy) for the production of CTI's drug candidate pixantrone.
The North American Center for Continuing Medical Education, LLC , in partnership with HMP Communications, LLC, publisher of EP Lab Digest, today announced several key sessions on the treatment of atrial fibrillation at the upcoming Electrophysiology Innovations Congress EP Innovations 2010, the world's premier annual electrophysiology meeting, to be held December 9-11, 2010, at the Washington Hilton in Washington, DC.
› Verified 6 days ago